Tag:
ovarian cancer
Latest Headlines
Latest Headlines
ASCO data to shine new light on Pfizer, Roche, J&J drugs
Cancer drug aficionados, rejoice. A slew of new studies goes public later today, as drugmakers gear up for next month's American Society of Clinical Oncology meeting.
Merck snags rights to Endocyte's ovarian cancer drug in $1B deal
Merck has scooped up worldwide rights to Endocyte's late-stage ovarian cancer drug in a billion-dollar deal.
'Hitchhiking' gold nanostars can sneak into cancer cells
Researchers at Northwestern University are touting some positive results for an inventive drug delivery method.
EntreMed lands $10M deal to fund cancer drug trials
EntreMed ( $ENMD ) has struck a deal to bring in much-needed capital to support development of its experimental kinase inhibitor for attacking multiple types of cancer. And the Rockville, MD-based drug
AZ commits $140M to cancer pact as it inks back-to-back deals
A day after AstraZeneca ( $AZN ) managed to raise fresh doubts about its ability to efficiently develop new therapies with twin setbacks in the clinic, the pharma company is back with a pair of new
AstraZeneca buries one program as second drug stumbles again in PhIII
AstraZeneca ( $AZN ) has back-to-back setbacks to report on a pair of key drug development programs. The pharma giant reported that it's burying the ovarian cancer drug program for olaparib after
Bavarian Nordic sees positive results in small therapeutic cancer vax study
Just weeks after gaining rights to an off-the-shelf therapeutic cancer vaccine involved in a collaboration with the NCI and NIH, Bavarian Nordic says that CV-301 produced some positive results in a
EntreMed shares spike on PhII cancer data
Shares of EntreMed ( $ENMD ) shot up 18% this morning after the developer posted final data on its primary endpoint for the ovarian cancer drug ENMD-2076. Investigators reported that 22% of the 64
Green dye lights up hidden ovarian tumor targets for cancer surgeons
Working around the concept that ovarian tumors contain more folate receptors than healthy tissue, a group of scientists has developed a new method to tag folate with a fluorescent dye and use the
Researchers find faulty gene responsible for some ovarian cancers
The RAD51D gene is ordinarily involved in repairing damaged DNA. But, in rare cases of a mutation, women have about a one in 11 chance of developing ovarian cancer. The discovery is being called the
